This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ucl Business Plc. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Nicky John Willis: Innovator in Pharmaceutical Compounds
Introduction
Nicky John Willis is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors of Notum. His work is aimed at addressing diseases that can be ameliorated through the inhibition of this enzyme.
Latest Patents
Nicky John Willis holds a patent for "Compounds which are inhibitors of Notum." This innovative compound is designed for use in the treatment of diseases that benefit from the inhibition of Notum, specifically outlined in the patent as formula (I).
Career Highlights
Willis is associated with UCL Business Plc, where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic areas, showcasing his commitment to improving health outcomes through innovative solutions.
Collaborations
Throughout his career, Nicky John Willis has collaborated with talented individuals such as Luca Vecchia and Edith Yvonne Jones. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Nicky John Willis is a distinguished inventor whose work in pharmaceutical compounds exemplifies innovation in the treatment of diseases. His contributions are paving the way for future advancements in medical science.